Mirum Pharmaceuticals, Inc. (MIRM) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$23.36M | +73.4% |
| 2024 | -$87.94M | +46.2% |
| 2023 | -$163.41M | -20.5% |
| 2022 | -$135.66M | -61.5% |
| 2021 | -$83.99M | +18.7% |
| 2020 | -$103.27M | -96.5% |
| 2019 | -$52.55M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$23.36M | +73.4% |
| 2024 | -$87.94M | +46.2% |
| 2023 | -$163.41M | -20.5% |
| 2022 | -$135.66M | -61.5% |
| 2021 | -$83.99M | +18.7% |
| 2020 | -$103.27M | -96.5% |
| 2019 | -$52.55M | — |